Related Experiment Videos
Chronic heart failure as a metabolic disorder
1Franz-Volhard-Klinik (Charité Campus Berlin-Buch), Max-Delbrück Centrum, Berlin, Germany.
Heart Failure Monitor
|March 14, 2003
Summary
Heart failure involves complex interactions between neurohormonal and metabolic issues, impacting immune function. Understanding these connections, including tumor necrosis factor-alpha (TNF-alpha), is crucial for managing cardiac cachexia and improving patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Immunology
Background:
- Congestive chronic heart failure (CHF) involves complex interactions of hemodynamic, neurohormonal, and metabolic disturbances.
- Neurohormonal abnormalities are recognized as key drivers of heart failure progression, leading to therapeutic advancements.
Purpose of the Study:
- To review the interactions between neurohormonal pathways and metabolic problems in CHF.
- To highlight the role of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), in heart failure pathophysiology.
Main Methods:
- Literature review focusing on neuroendocrine, hormonal, and inflammatory pathways in CHF.
- Analysis of the interplay between energy metabolism, immune function, and hormonal regulation.
Main Results:
- Tumor necrosis factor-alpha (TNF-alpha) is identified as a key molecule linking energy metabolism, immune function, and neuroendocrine pathways.
- Cardiac cachexia, a severe metabolic complication in CHF, currently lacks specific therapies and has a poor prognosis.
Conclusions:
- Promising therapeutic strategies targeting TNF-alpha or growth factors exist but carry risks and high costs.
- Future CHF management requires comprehensive assessment beyond cardiac function, including metabolic status, body composition, and hormonal profiles.